How does elafibranor reduce bile acid toxicity?

Elafibranor and its active metabolite activate PPAR receptors, reducing bile acid synthesis, increasing detoxification, modulating bile acid output and regulating transporters that absorb and secrete bile components, thereby reducing bile toxicity and injury to bile duct and liver cells.